Japanese Assessment of BMIPP and CTA for Diagnostic utility in Suspected Angina Patients
- Conditions
- Ischemic heart disease
- Registration Number
- JPRN-UMIN000007606
- Lead Sponsor
- Kansai Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 150
Not provided
1)History of myocardial infarction 2)Acute coronary syndrome 3)History of hospitalization by heart failuer 4)History of coronary revascularization 5)CKD patient(eGFR<=50mL/min/1.73m2) 6)Uncontrollable arrhythmia or AF 7)Uncontrollable hypertension 8)Overt valve regurgitation and/or moderate to severe valvular disease on UCG 9)Coronary angiography or CT angiography within 2 months before registration 10)Drug hypersensitivity with BMIPP and Tetrofosmin 11)Unsuitable for registration by investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method